SERINE PROTEASE INHIBITORY EFFECTS OF HEALTH SUPPLEMENTS IN HUMAN CANCERUS CELL LINES
The present invention relates generally to a method of detecting inhibitory effects of health supplements on serine protease in cell lines derived from human carcinomas. More, particularly, the present invention relates to inhibitory analysis of health supplementary products taken from market and/or...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SRICHANA, Teerapol SIL, Kumar Bijon PAUL, Kumar Pijush |
| description | The present invention relates generally to a method of detecting inhibitory effects of health supplements on serine protease in cell lines derived from human carcinomas. More, particularly, the present invention relates to inhibitory analysis of health supplementary products taken from market and/or chemically purified forms, in order to determine their competitors and/or inhibitory effects on serine protease such as trypsin so that these supplements can be used for the treatment once someone develop intense inflammatory reactions either due to infections like COVID-19 and/or pathological conditions such as cancer. The present invention further provides therapeutic applications for agents and/or condition which utilize human enzymatic system and/or cellular components for the development of pathological conditions.
La présente invention concerne de manière générale un procédé de détection d'effets inhibiteurs de compléments alimentaires sur la sérine protéase dans des lignées cellulaires dérivées de carcinomes humains. Plus particulièrement, la présente invention concerne l'analyse inhibitrice de produits de compléments alimentaires prélevés du marché et/ou des formes chimiquement purifiées, afin de déterminer leurs concurrents et/ou effets inhibiteurs sur la sérine protéase comme la trypsine, de telle sorte que ces compléments peuvent être utilisés pour le traitement une fois que quelqu'un développe des réactions inflammatoires intenses soit en raison d'infections telles que la COVID-19 et/ou d'états pathologiques tels que le cancer. La présente invention concerne en outre des applications thérapeutiques pour des agents et/ou un état qui utilisent un système enzymatique humain et/ou des composants cellulaires pour le développement d'états pathologiques. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024144461A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024144461A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024144461A13</originalsourceid><addsrcrecordid>eNqNjDEKAjEQANNYiPqHBWvBnME-hg0J5DYhmyBWxyGxEj04_49X-ACrgWGYtaiM2RNCyrGgZgRPzl98ifkGaC2awhAtONShOOCaUsAeabGewNVeExhNBnNlMBgChOXGW7F6jM-57X7ciL3FYtyhTe-hzdN4b6_2Ga6xO3ZKKqXOUsvTf9UXLXQxWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SERINE PROTEASE INHIBITORY EFFECTS OF HEALTH SUPPLEMENTS IN HUMAN CANCERUS CELL LINES</title><source>esp@cenet</source><creator>SRICHANA, Teerapol ; SIL, Kumar Bijon ; PAUL, Kumar Pijush</creator><creatorcontrib>SRICHANA, Teerapol ; SIL, Kumar Bijon ; PAUL, Kumar Pijush</creatorcontrib><description>The present invention relates generally to a method of detecting inhibitory effects of health supplements on serine protease in cell lines derived from human carcinomas. More, particularly, the present invention relates to inhibitory analysis of health supplementary products taken from market and/or chemically purified forms, in order to determine their competitors and/or inhibitory effects on serine protease such as trypsin so that these supplements can be used for the treatment once someone develop intense inflammatory reactions either due to infections like COVID-19 and/or pathological conditions such as cancer. The present invention further provides therapeutic applications for agents and/or condition which utilize human enzymatic system and/or cellular components for the development of pathological conditions.
La présente invention concerne de manière générale un procédé de détection d'effets inhibiteurs de compléments alimentaires sur la sérine protéase dans des lignées cellulaires dérivées de carcinomes humains. Plus particulièrement, la présente invention concerne l'analyse inhibitrice de produits de compléments alimentaires prélevés du marché et/ou des formes chimiquement purifiées, afin de déterminer leurs concurrents et/ou effets inhibiteurs sur la sérine protéase comme la trypsine, de telle sorte que ces compléments peuvent être utilisés pour le traitement une fois que quelqu'un développe des réactions inflammatoires intenses soit en raison d'infections telles que la COVID-19 et/ou d'états pathologiques tels que le cancer. La présente invention concerne en outre des applications thérapeutiques pour des agents et/ou un état qui utilisent un système enzymatique humain et/ou des composants cellulaires pour le développement d'états pathologiques.</description><language>eng ; fre</language><subject>FODDER ; FOODS OR FOODSTUFFS ; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL ; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240704&DB=EPODOC&CC=WO&NR=2024144461A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240704&DB=EPODOC&CC=WO&NR=2024144461A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SRICHANA, Teerapol</creatorcontrib><creatorcontrib>SIL, Kumar Bijon</creatorcontrib><creatorcontrib>PAUL, Kumar Pijush</creatorcontrib><title>SERINE PROTEASE INHIBITORY EFFECTS OF HEALTH SUPPLEMENTS IN HUMAN CANCERUS CELL LINES</title><description>The present invention relates generally to a method of detecting inhibitory effects of health supplements on serine protease in cell lines derived from human carcinomas. More, particularly, the present invention relates to inhibitory analysis of health supplementary products taken from market and/or chemically purified forms, in order to determine their competitors and/or inhibitory effects on serine protease such as trypsin so that these supplements can be used for the treatment once someone develop intense inflammatory reactions either due to infections like COVID-19 and/or pathological conditions such as cancer. The present invention further provides therapeutic applications for agents and/or condition which utilize human enzymatic system and/or cellular components for the development of pathological conditions.
La présente invention concerne de manière générale un procédé de détection d'effets inhibiteurs de compléments alimentaires sur la sérine protéase dans des lignées cellulaires dérivées de carcinomes humains. Plus particulièrement, la présente invention concerne l'analyse inhibitrice de produits de compléments alimentaires prélevés du marché et/ou des formes chimiquement purifiées, afin de déterminer leurs concurrents et/ou effets inhibiteurs sur la sérine protéase comme la trypsine, de telle sorte que ces compléments peuvent être utilisés pour le traitement une fois que quelqu'un développe des réactions inflammatoires intenses soit en raison d'infections telles que la COVID-19 et/ou d'états pathologiques tels que le cancer. La présente invention concerne en outre des applications thérapeutiques pour des agents et/ou un état qui utilisent un système enzymatique humain et/ou des composants cellulaires pour le développement d'états pathologiques.</description><subject>FODDER</subject><subject>FOODS OR FOODSTUFFS</subject><subject>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</subject><subject>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKAjEQANNYiPqHBWvBnME-hg0J5DYhmyBWxyGxEj04_49X-ACrgWGYtaiM2RNCyrGgZgRPzl98ifkGaC2awhAtONShOOCaUsAeabGewNVeExhNBnNlMBgChOXGW7F6jM-57X7ciL3FYtyhTe-hzdN4b6_2Ga6xO3ZKKqXOUsvTf9UXLXQxWA</recordid><startdate>20240704</startdate><enddate>20240704</enddate><creator>SRICHANA, Teerapol</creator><creator>SIL, Kumar Bijon</creator><creator>PAUL, Kumar Pijush</creator><scope>EVB</scope></search><sort><creationdate>20240704</creationdate><title>SERINE PROTEASE INHIBITORY EFFECTS OF HEALTH SUPPLEMENTS IN HUMAN CANCERUS CELL LINES</title><author>SRICHANA, Teerapol ; SIL, Kumar Bijon ; PAUL, Kumar Pijush</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024144461A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>FODDER</topic><topic>FOODS OR FOODSTUFFS</topic><topic>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</topic><topic>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SRICHANA, Teerapol</creatorcontrib><creatorcontrib>SIL, Kumar Bijon</creatorcontrib><creatorcontrib>PAUL, Kumar Pijush</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SRICHANA, Teerapol</au><au>SIL, Kumar Bijon</au><au>PAUL, Kumar Pijush</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SERINE PROTEASE INHIBITORY EFFECTS OF HEALTH SUPPLEMENTS IN HUMAN CANCERUS CELL LINES</title><date>2024-07-04</date><risdate>2024</risdate><abstract>The present invention relates generally to a method of detecting inhibitory effects of health supplements on serine protease in cell lines derived from human carcinomas. More, particularly, the present invention relates to inhibitory analysis of health supplementary products taken from market and/or chemically purified forms, in order to determine their competitors and/or inhibitory effects on serine protease such as trypsin so that these supplements can be used for the treatment once someone develop intense inflammatory reactions either due to infections like COVID-19 and/or pathological conditions such as cancer. The present invention further provides therapeutic applications for agents and/or condition which utilize human enzymatic system and/or cellular components for the development of pathological conditions.
La présente invention concerne de manière générale un procédé de détection d'effets inhibiteurs de compléments alimentaires sur la sérine protéase dans des lignées cellulaires dérivées de carcinomes humains. Plus particulièrement, la présente invention concerne l'analyse inhibitrice de produits de compléments alimentaires prélevés du marché et/ou des formes chimiquement purifiées, afin de déterminer leurs concurrents et/ou effets inhibiteurs sur la sérine protéase comme la trypsine, de telle sorte que ces compléments peuvent être utilisés pour le traitement une fois que quelqu'un développe des réactions inflammatoires intenses soit en raison d'infections telles que la COVID-19 et/ou d'états pathologiques tels que le cancer. La présente invention concerne en outre des applications thérapeutiques pour des agents et/ou un état qui utilisent un système enzymatique humain et/ou des composants cellulaires pour le développement d'états pathologiques.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024144461A1 |
| source | esp@cenet |
| subjects | FODDER FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES |
| title | SERINE PROTEASE INHIBITORY EFFECTS OF HEALTH SUPPLEMENTS IN HUMAN CANCERUS CELL LINES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A31%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SRICHANA,%20Teerapol&rft.date=2024-07-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024144461A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |